EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 299 filers reported holding EXELIXIS INC in Q1 2018. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,111 | +19.4% | 234,132 | +4.7% | 0.01% | +20.0% |
| Q2 2023 | $4,281 | -12.7% | 223,637 | -11.4% | 0.01% | -16.7% |
| Q1 2023 | $4,901 | +19.2% | 252,271 | -1.4% | 0.01% | +9.1% |
| Q4 2022 | $4,112 | -99.9% | 255,978 | +19.7% | 0.01% | +10.0% |
| Q3 2022 | $3,349,000 | -18.7% | 213,803 | +8.2% | 0.01% | -9.1% |
| Q2 2022 | $4,117,000 | +3.2% | 197,666 | +15.4% | 0.01% | +37.5% |
| Q1 2022 | $3,990,000 | +37.1% | 171,286 | +7.5% | 0.01% | +33.3% |
| Q4 2021 | $2,911,000 | -7.3% | 159,345 | +8.0% | 0.01% | -14.3% |
| Q3 2021 | $3,141,000 | +41.7% | 147,502 | +21.2% | 0.01% | +40.0% |
| Q2 2021 | $2,216,000 | -18.7% | 121,654 | +0.7% | 0.01% | -28.6% |
| Q1 2021 | $2,726,000 | +5.3% | 120,806 | -6.4% | 0.01% | +40.0% |
| Q4 2020 | $2,588,000 | -26.9% | 129,007 | -11.1% | 0.01% | -37.5% |
| Q3 2020 | $3,541,000 | -2.6% | 145,083 | -5.3% | 0.01% | 0.0% |
| Q2 2020 | $3,637,000 | +34.1% | 153,217 | -3.0% | 0.01% | +14.3% |
| Q1 2020 | $2,712,000 | +6.6% | 157,931 | +8.5% | 0.01% | +16.7% |
| Q4 2019 | $2,545,000 | -67.9% | 145,556 | -67.4% | 0.01% | -68.4% |
| Q3 2019 | $7,919,000 | -24.4% | 446,837 | -8.8% | 0.02% | -20.8% |
| Q2 2019 | $10,474,000 | +103.3% | 490,014 | +126.1% | 0.02% | +71.4% |
| Q1 2019 | $5,152,000 | +56.2% | 216,765 | +19.9% | 0.01% | +55.6% |
| Q4 2018 | $3,299,000 | +9.1% | 180,782 | +6.0% | 0.01% | +28.6% |
| Q3 2018 | $3,024,000 | +340.2% | 170,590 | +434.9% | 0.01% | +250.0% |
| Q2 2018 | $687,000 | -10.7% | 31,890 | -8.0% | 0.00% | 0.0% |
| Q1 2018 | $769,000 | -26.9% | 34,671 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $1,052,000 | +25.5% | 34,671 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $838,000 | -1.6% | 34,671 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $852,000 | +39.0% | 34,671 | +22.3% | 0.00% | 0.0% |
| Q1 2017 | $613,000 | +83.0% | 28,342 | +26.9% | 0.00% | +100.0% |
| Q4 2016 | $335,000 | -51.9% | 22,342 | -59.0% | 0.00% | 0.0% |
| Q3 2016 | $696,000 | +228.3% | 54,484 | +100.0% | 0.00% | 0.0% |
| Q2 2016 | $212,000 | +94.5% | 27,242 | 0.0% | 0.00% | – |
| Q1 2016 | $109,000 | -28.8% | 27,242 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $153,000 | 0.0% | 27,242 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $153,000 | +273.2% | 27,242 | +149.0% | 0.00% | – |
| Q2 2015 | $41,000 | +46.4% | 10,942 | 0.0% | 0.00% | – |
| Q1 2015 | $28,000 | +75.0% | 10,942 | 0.0% | 0.00% | – |
| Q4 2014 | $16,000 | -5.9% | 10,942 | 0.0% | 0.00% | – |
| Q3 2014 | $17,000 | -63.0% | 10,942 | -20.1% | 0.00% | – |
| Q2 2014 | $46,000 | +21.1% | 13,692 | +25.1% | 0.00% | – |
| Q1 2014 | $38,000 | -51.9% | 10,942 | -15.5% | 0.00% | – |
| Q4 2013 | $79,000 | – | 12,942 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 17,416,738 | $422,007,000 | 64.06% |
| Matrix Capital Management Company, LP | 15,117,460 | $366,296,000 | 11.71% |
| Rhenman & Partners Asset Management AB | 1,050,000 | $25,442,000 | 3.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 254,334 | $6,163,000 | 2.40% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 790,148 | $19,145,000 | 1.30% |
| Jupiter Investment Management Ltd | 4,182,760 | $101,348,000 | 1.06% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 50,818 | $1,231,000 | 0.70% |
| C M BIDWELL & ASSOCIATES LTD | 17,475 | $423,000 | 0.65% |
| QCM Cayman, Ltd. | 9,562 | $232,000 | 0.60% |
| Handelsinvest Investeringsforvaltning | 98,500 | $2,387,000 | 0.56% |